Procurement Summary
Country : USA
Summary : Smartseq Reagent Kits
Deadline : 19 Jul 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 104020910
Document Ref. No. : SS-NIAID-24-2226785
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
This is a Sources Sought notice for domestically manufactured products only. This is NOT a solicitation for proposals, proposal abstracts, or quotations. Per the Buy American Act and Executive Order 14005, the National Institutes of Allergy & Infectious Disease (NIAID) is seeking information for domestically manufactured products only, Per the requirements under the Buy American Act and requirements relating to Executive Order 14005 entitled: “Ensuring the Future is Made in All of America by All of America-s Workers”, in the event that a nonavailability waiver request submitted through the Made in America Office (MIAO)-s Digital Waiver Portal is required." Respondents must certify in capabilities statement that products are manufactured in the United States.
The purpose of this notice is to obtain information regarding the availability and capability of all U.S manufactured products that are equal to the following product:
WE ARE SEEKING SMARTSEQ REAGENT KITS: 10x Lysis Buffer to efficiently disrupt cellular membranes for the release of RNA; Reverse Transcriptase for the initiation of unbiased cDNA synthesis, allowing for amplification and library construction from any RNA transcript; RNAse Inhibitor to prevent the degradation of the cellular RNA; and DNA Polymerase, a high-fidelity PCR enzyme with hot start capabilities that is especially well suited for use with specific SMARTer kits for transcriptome analysis (NGS).
The essential specifications and capabilities needed are:
1. 10x Lysis Buffer, Catalog#: 635013, QTY of 1
2. SMARTScribe RT, Catalog#: 639538, QTY of 12
3. RNAse Inhibitor, Catalog#: 2313B, QTY of 12
4. SeqAmp DNA Polymerase, Catalog#: 638509, QTY of 10
Capability Statement/Information Sought
All capable vendors should respond with a brief capability statement demonstrating an equal product that is manufactured in the United States by July 19, 2024, by 11:00 AM EST....
Active Contract Opportunity Notice ID SS-NIAID-24-2226785 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Sources Sought (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Jul 10, 2024 09:01 am EDT
Original Response Date: Jul 19, 2024 11:00 am EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Aug 03, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing
Place of Performance: Rockville, MD 20852 USA
Documents
Tender Notice